Rapid Micro Biosystems, Inc. (RPID)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Rapid Micro Biosystems Q1 Earnings Call Highlights
Rapid Micro Biosystems NASDAQ: RPID reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while management said gross margin improvement remains a central priority for the year.
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.26 per share a year ago.
Rapid Micro Biosystems, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| WH William Herlihy RESOURCES MANAGEMENT Corp. /CT/ /ADV | 500 | $1,359 | $1,060 | -$299 | -22% |
| RF Rekah Franca Catalyst Funds Management Pty Ltd. | 21,200 | $48,124 | $45,753.84 | -$2,370.16 | -4.93% |
 Kevin Stillman Evernest Financial Advisors, LLC | 432,510 | $1.14M | $906,108.45 | -$237,115.7 | -20.74% |
Rapid Micro Biosystems, Inc. (RPID) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Rapid Micro Biosystems, Inc. ever had a stock split?
Rapid Micro Biosystems, Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Robert G. Spignesi Jr. CEO | NASDAQ (CM) Exchange | 75340L104 CUSIP |
| US Country | 171 Employees | - Last Dividend | 29 Oct 2010 Last Split | 15 Jul 2021 IPO Date |
Overview
Rapid Micro Biosystems, Inc., a pioneering life sciences technology entity, plays a crucial role in safeguarding the manufacture of pharmaceuticals, medical devices, and personal care products against microbial contamination. The company's reach spans across various critical markets including the United States, Germany, Switzerland, Japan, and other global locations. Commencing its journey in 2006, the company, initially known as Genomic Profiling Systems, Inc., adopted its current name in January 2007. Since its inception, Rapid Micro Biosystems has committed to advancing and streamlining the microbial quality control (MQC) processes critical to the production of biologics, vaccines, cell and gene therapies, and sterile injectables, among other therapeutic modalities. The headquarters of this innovative firm is located in Lowell, Massachusetts, reflecting its tie to one of the United States' hubs for biotechnology and life sciences innovation.
Products and Services
Rapid Micro Biosystems, Inc. is distinguished by its comprehensive suite of products and services designed to automate and refine the microbial detection process in quality control laboratories. Their flagship is the Growth Direct™ platform, which is composed of several key components:
- Growth Direct System: This automated system revolutionizes traditional microbial quality control testing by expediting the detection process and ensuring higher accuracy and repeatability.
- Proprietary Consumables: Tailored for use with the Growth Direct system, these consumables ensure optimal performance and reliability of microbial detection processes.
- Lab Information Management System (LIMS) Connection Software: This software facilitates seamless integration between the Growth Direct system and a laboratory's LIMS, ensuring efficient data management and reporting.
- Customer Support and Validation Services: Rapid Micro Biosystems provides extensive customer support and validation services, ensuring that clients can fully leverage the capabilities of the Growth Direct platform with confidence.
Furthermore, the company offers a range of specialized software solutions to enhance the functionality and user experience of the Growth Direct system:
- RMBNucleus Software: A cornerstone software component for managing Growth Direct system operations, enhancing efficiency, and streamlining workflow processes.
- RMBNucleus Mold Alarm: An early warning system that alerts laboratory personnel at the first sign of mold detection, enhancing response time and mitigative actions.
- RMBNucleus Central Manager Portal: This tool enables centralized coordination and management of multiple Growth Direct instruments, fostering operational synergies across extensive laboratory networks.
- Growth Direct LIMS Connection Software: Enhancing laboratory efficiency through direct software linkages, this software ensures the seamless communication between Growth Direct systems and laboratory information management systems.
Designed for applications ranging from environmental monitoring and water testing to bioburden and sterility release testing, Rapid Micro Biosystems' solutions are integral to ensuring the microbial safety and compliance of pharmaceuticals, medical devices, and personal care products. The company also emphasizes the importance of education and competency in the use of its systems by providing onsite technical training services, ensuring that their clients are well-equipped to implement these advanced microbial quality control solutions.
